Implementing drug checking as an illicit drug market intervention within the supply chain in a Canadian setting

被引:20
作者
Wallace, Bruce [1 ,2 ]
van Roode, Thea [1 ]
Burek, Piotr [1 ]
Pauly, Bernadette [1 ,3 ]
Hore, Dennis [4 ,5 ]
机构
[1] Univ Victoria, Canadian Inst Subst Use Res, Victoria, BC, Canada
[2] Univ Victoria, Sch Social Work, Victoria, BC, Canada
[3] Univ Victoria, Sch Nursing, Victoria, BC, Canada
[4] Univ Victoria, Dept Chem, Victoria, BC, Canada
[5] Univ Victoria, Dept Comp Sci, Victoria, BC, Canada
关键词
Drug checking; harm reduction; substance use; fentanyl; overdose; implementation science; consolidated framework for implementation research; PUBLIC-HEALTH; FENTANYL; OVERDOSE;
D O I
10.1080/09687637.2022.2087487
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This research explored drug checking as a market intervention with a potential role in supporting a safer supply within the overdose crisis. We sought the perspectives of potential service users, including those who sell substances. Twenty-six semi-structured interviews were conducted in Victoria, British Columbia (BC), Canada with research guided by the Consolidated Framework for Implementation Research (CFIR). We identified five overarching themes for implementation: 'Understanding the role of conflicting policies and market pressures,' 'Increasing relative advantage of drug checking through quality results and written reports,' 'Establishing safe, discrete locations without the risk of arrest or public knowledge,' 'Partnering peers with drug knowledge and skilled technicians,' and 'Engaging peers and word of mouth to ensure trust and reputation.' We heard that criminalization and being responsive to market pressures are the most critical factors in implementing drug checking as a market intervention. To operate within this context, drug checking services need to ensure the provision of high-quality services and products, provided by peers and scientists, with established trust and safety. Promotion of drug checking to facilitate quality products and novel strategies were identified, but pose challenges. Continued development of drug checking technologies and methods is required to be relevant and responsive.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 49 条
[1]   Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking [J].
Bardwell, Geoff ;
Boyd, Jade ;
Arredondo, Jaime ;
McNeil, Ryan ;
Kerr, Thomas .
DRUG AND ALCOHOL DEPENDENCE, 2019, 198 :1-6
[2]  
Barratt MJ., 2018, GLOBAL REV DRUG CHEC
[3]   "I couldn't live with killing one of my friends or anybody": A rapid ethnographic study of drug sellers' use of drug checking [J].
Betsos, Alex ;
Valleriani, Jenna ;
Boyd, Jade ;
Bardwell, Geoff ;
Kerr, Thomas ;
McNeil, Ryan .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 87
[4]  
Bonn M, 2020, J STUD ALCOHOL DRUGS, V81, P556, DOI 10.15288/jsad.2020.81.556
[5]   A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry [J].
Borden, Scott A. ;
Saatchi, Armin ;
Vandergrift, Gregory W. ;
Palaty, Jan ;
Lysyshyn, Mark ;
Gill, Chris G. .
DRUG AND ALCOHOL REVIEW, 2022, 41 (02) :410-418
[6]   Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications [J].
Bowles, Jeanette M. ;
McDonald, Karen ;
Maghsoudi, Nazlee ;
Thompson, Hayley ;
Stefan, Cristiana ;
Beriault, Daniel R. ;
Delaney, Sarah ;
Wong, Ernest ;
Werb, Dan .
HARM REDUCTION JOURNAL, 2021, 18 (01)
[7]  
British Columbia Coroners Service, 2020, ILL DRUG TOX DEATHS
[8]   Auras of Detection: Power and Knowledge in Drug Prohibition [J].
Carroll, Jennifer J. .
CONTEMPORARY DRUG PROBLEMS, 2021, 48 (04) :327-345
[9]   The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis [J].
Ciccarone, Daniel .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 71 :183-188
[10]   Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin' [J].
Ciccarone, Daniel ;
Ondocsin, Jeff ;
Mars, Sarah G. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 :146-155